Simplex Trading’s Tempest Therapeutics TPST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-808
Closed -$3K 9744
2025
Q1
$3K Buy
808
+516
+177% +$5.85K ﹤0.01% 7891
2024
Q4
$3K Sell
292
-31
-10% -$400 ﹤0.01% 7940
2024
Q3
$5K Sell
323
-285
-47% -$5.84K ﹤0.01% 7651
2024
Q2
$17K Sell
608
-1,054
-63% -$45.6K ﹤0.01% 7053
2024
Q1
$84K Buy
1,662
+277
+20% +$14K ﹤0.01% 5766
2023
Q4
$79K Buy
+1,385
New +$65.6K ﹤0.01% 5618
2021
Q4
Sell
-1,531
Closed -$220K 11440
2021
Q3
$220K Hold
1,531
﹤0.01% 5444
2021
Q2
$222K Buy
+1,531
New +$344K ﹤0.01% 5526
2021
Q1
Hold
0
8490
2020
Q4
Sell
-2
Closed -$61K 9096
2020
Q3
$61K Buy
2
+1
+100% +$339 ﹤0.01% 5423
2020
Q2
$46K Sell
1
-9
-90% -$3.59K ﹤0.01% 5573
2020
Q1
$1.07M Buy
+10
New +$14.6K ﹤0.01% 1826
2017
Q4
Hold
0
-$5K 6695
2017
Q3
Hold
0
4431
2017
Q2
Hold
0
5741
2016
Q4
Hold
0
-$1K 6532
2016
Q3
Hold
0
5444
2016
Q2
Hold
0
-$40K 6460
2016
Q1
Hold
0
2154
2015
Q4
Hold
0
2046
2015
Q3
Hold
0
1485
2015
Q2
Hold
0
3547
2015
Q1
Hold
0
2715

Other funds holding TPST

Simplex Trading's TPST Position: Q2 2025 in Review

Simplex Trading sold out of Tempest Therapeutics (TPST) in Q2 2025, closing a stake of 1,571 shares — an estimated $15K sold.

Simplex Trading first reported a position in TPST in Q1 2015 and held it in 14 quarters. The position peaked at $296K in Q4 2023. 18 funds tracked by Wall St. Rank hold TPST as of Q2 2025.

  • Simplex Trading reported no remaining Tempest Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 1,571 Tempest Therapeutics shares in Q2 2025, an estimated $15K.
  • Simplex Trading first reported a position in Tempest Therapeutics in Q1 2015 and held it in 14 quarters.
  • Simplex Trading's Tempest Therapeutics position peaked at $296K in Q4 2023.
  • 18 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.